Literature DB >> 15220197

Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1.

Marie-Line Peyot1, Christopher J Nolan, Krishnakant Soni, Erik Joly, Roxane Lussier, Barbara E Corkey, Shu Pei Wang, Grant A Mitchell, Marc Prentki.   

Abstract

We previously reported decreased glucose-stimulated insulin secretion (GSIS) in hormone-sensitive lipase-null mice (HSL(-/-)), both in vivo and in vitro. The focus of the current study was to gain further insight into the signaling role and regulation of lipolysis in islet tissue. The effect of glucagon-like peptide 1 (GLP-1) on GSIS was also studied, as GLP-1 could augment GSIS via protein kinase A activation of HSL and lipolysis. Freshly isolated islets from fasted and fed male HSL(-/-) and wild-type (HSL(+/+)) mice were studied at ages 4 and 7 months. Neutral cholesteryl ester hydrolase activity was markedly reduced in islets from both 4- and 7-month-old male HSL(-/-) mice, whereas a marked deficiency in triglyceride lipase activity became evident only in the older mice. The deficiencies in lipase activities were associated with higher islet triglyceride content and reduced lipolysis at basal glucose levels. Lipolysis was stimulated by high glucose in islets of both wild-type and HSL-null mice. Severe deficiencies in GSIS were found, but only in islets from 7-month-old, fasted, male HSL(-/-) mice. GSIS was less affected in 4-month-old fasted male HSL(-/-) mice and not reduced in female mice. Exogenous delivery of free fatty acids (FFAs) rescued GSIS, supporting the view that the lack of endogenous FFA supply for lipid-signaling processes in HSL(-/-) mice was responsible for the loss of GSIS. GLP-1 also rescued GSIS in HSL(-/-) mice, indicating that signaling via HSL is not a major pathway for its incretin effect. Thus, the secretory phenotype of HSL-null mice is gender dependent, increases with age, and is influenced by the nutritional state. Under most circumstances, the major determinant of lipolytic flux in the beta-cell involves an enzyme(s) other than HSL that is acutely activated by glucose. Our results support the view that the availability of endogenous FFA through HSL and an additional enzyme(s) is involved in providing lipid moieties for beta-cell signaling for secretion in response to glucose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220197     DOI: 10.2337/diabetes.53.7.1733

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

Review 1.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

2.  Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.

Authors:  Hannah J Welters; Abdelfattah El Ouaamari; Dan Kawamori; John Meyer; Jiang Hu; David M Smith; Rohit N Kulkarni
Journal:  Endocrinology       Date:  2012-07-17       Impact factor: 4.736

3.  Simplified assays of lipolysis enzymes for drug discovery and specificity assessment of known inhibitors.

Authors:  Jose Iglesias; Julien Lamontagne; Heidi Erb; Sari Gezzar; Shangang Zhao; Erik Joly; Vouy Linh Truong; Kathryn Skorey; Sheldon Crane; S R Murthy Madiraju; Marc Prentki
Journal:  J Lipid Res       Date:  2015-09-30       Impact factor: 5.922

4.  Deletion of the gene encoding G0/G 1 switch protein 2 (G0s2) alleviates high-fat-diet-induced weight gain and insulin resistance, and promotes browning of white adipose tissue in mice.

Authors:  Wissal El-Assaad; Karim El-Kouhen; Amro H Mohammad; Jieyi Yang; Masahiro Morita; Isabelle Gamache; Orval Mamer; Daina Avizonis; Nicole Hermance; Sander Kersten; Michel L Tremblay; Michelle A Kelliher; Jose G Teodoro
Journal:  Diabetologia       Date:  2014-11-09       Impact factor: 10.122

Review 5.  Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges.

Authors:  Julien Ghislain; Vincent Poitout
Journal:  Nat Rev Endocrinol       Date:  2021-01-25       Impact factor: 43.330

6.  Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.

Authors:  Marie-Line Peyot; Joshua P Gray; Julien Lamontagne; Peter J S Smith; George G Holz; S R Murthy Madiraju; Marc Prentki; Emma Heart
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

7.  Adipose triglyceride lipase is implicated in fuel- and non-fuel-stimulated insulin secretion.

Authors:  Marie-Line Peyot; Claudiane Guay; Martin G Latour; Julien Lamontagne; Roxane Lussier; Marco Pineda; Neil B Ruderman; Guenter Haemmerle; Rudolf Zechner; Erik Joly; S R Murthy Madiraju; Vincent Poitout; Marc Prentki
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

8.  Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations.

Authors:  Julien Lamontagne; Emilie Pepin; Marie-Line Peyot; Erik Joly; Neil B Ruderman; Vincent Poitout; S R Murthy Madiraju; Christopher J Nolan; Marc Prentki
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

9.  Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.

Authors:  Kim M Huffman; Svati H Shah; Robert D Stevens; James R Bain; Michael Muehlbauer; Cris A Slentz; Charles J Tanner; Maragatha Kuchibhatla; Joseph A Houmard; Christopher B Newgard; William E Kraus
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

10.  Deletion of PKCepsilon selectively enhances the amplifying pathways of glucose-stimulated insulin secretion via increased lipolysis in mouse beta-cells.

Authors:  James Cantley; James G Burchfield; Gemma L Pearson; Carsten Schmitz-Peiffer; Michael Leitges; Trevor J Biden
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.